The primary care update series is a new premium service from bpacnz
Find out more
Register to use all the features of this website, including selecting clinical areas of interest and
“favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially,
quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features
of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
A new direct-acting antiviral (DAA) oral regimen for the treatment of hepatitis C, glecaprevir + pibrentasvir (Maviret) will be...
Hepatitis C infection occurs through exposure to infected blood or body fluids. The majority of newly acquired infections in New...
Patients should be assessed for cirrhosis via clinical examination, laboratory tests and an APRI score (or liver elastography...
Glecaprevir + pibrentasvir is taken once daily for eight weeks. Headache and fatigue are the most likely adverse effects. HCV...
Dr Tony Farrell is a general practitioner in Mount Maunganui and has a Fellowship in Addiction Medicine. He has a special interest...
Tenofovir disoproxil and entecavir are once daily oral antiviral medicines, recommended as first-line treatments for patients...
Three new oral medicine regimens for the treatment of hepatitis C, known as directly acting antivirals (DAAs), are fully subsidised...
A guide focusing on some of the situations GPs face in day-to-day practice with practical advice for initial testing.
Copyright All Rights Reserved © bpacnz 2020
Follow us on facebook
View Guidelines »
Recertification programme »
Decision support for health professionals »
Info on the use of medicines in NZ »
South Island general practice support »
Practice acquisition and careers in health »